Estimation formula of glomerular filtration rate in the chronic renal insufficiency. Advantages and disadvantages in elders
Abstract
In this medical review the most frequent and updated mathematics equations to estimate gomerular filtration rate emerged in the latest decades are presented and its advantages and disadvantages in elderly patients, the basis for diagnosis and outcomes of Chronic Renal Insufficiency, its epidemiology and indicators are showed. To determine the progression of Chronic Renal Insufficiency particularly in this population of patients have considerable interest in the current nephrology, even though the existing literature points towards a beneficial of mathematics equations in patients presenting with low gomerular filtration rate but an integral clinical and humoral assessment of the disease is needed to assure the accuracy of diagnosis in elderly patients and on the other hand to rule out senile hypofiltration, thus more randomized controlled trials are still lacking to answer this question definitDownloads
References
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and iniciatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Internat. 2007; (72): 247-259.
Otero A, de Francisco A, Gayoso P, García F; EPIRCE Study Group. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrología. 2010; 30(1):78-86.
Atkins RC. The epidemiology of chronic kidney disease. Kidney Internat. 2005, Suppl(94): S14-8.
Praga M. Progresión de la insuficiencia renal crónica en el paciente geriátrico. Nefrología. 1997; 17; S3:68-72.
Alcazar MR, Egocheaga I, Orte L, Lobos JM, González Parra E, Álvarez Gisasola F, et al. Documento de consenso SEN-semFYC sobre enfermedad renal crónica. Nefrología. 2008; 28(3): 273-282.
Cuba. Oficina Nacional de Estadísticas. El envejecimiento de la población: Cuba y sus territorios. Cifras e indicadores para su estudio. La Habana: Centro de Estudios de Población y Desarrollo; 2007.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; (16): 31-41.
Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612.
Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and chronic kidney disease. J Am Soc Nephrol. 2005; 16: 459-466.
Levey AS, Greene T, Kusek JW, Beck GJ. Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000; 11: 828(A): 153-162.
National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-S266.
Montañés R, Bover J, Oliver A, Ballarín JA, Gracia S. Valoración de la nueva ecuación CKD-EPI para la estimación del filtrado glomerular. Nefrología. 2010; 30(2): 185-94.
Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, et al. Comparative performance of the CKD- Epidemiology Collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels above 60 ml/min/1.73m2. Am J Kid Dis. 2010; 56(3): 486-95.
Pequignot R, Belmin J, Chauvelier S, Gaubert JY, Konrat C, Duron E, Hanon O. Renal function in older hospital patients is more accurately estimated using the Cockcroft-Gault than the Modification Diet in Renal Disease formula. J Am Geriatr Soc. 2009; 57(9):1638-43.
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and chronic kidney disease. J Am Soc Nephrol. 2005; 16: 459-466.
Nicoll SR. Assessment of creatinine clearance in healthy subjects over 65 years of age. Nephron. 1991; 59(4):621-5.
Levey AS, Stevens LA, Coresh J. Conceptual Model of CKD: applications and implications. Am J Kidney Dis. 2009; 53(Suppl 3): S4-S16.
Ingelfinger Julie R, Marsden, Philip A. Estimated GFR and Risk of Death - Is Cystatin C Useful? New England J Med. 2013; 10: 974-975.
Shlipak MG, Matsushita K. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013; 369:932-943.
García de Vinuesa S. Factores de progresión de la enfermedad renal crónica. Prevención secundaria. Nefrología 2008; S3:17-21.
Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in Renal Disease Study. Ann Intern Med. 1995; 123:754-62.
Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Internat. 2006; 69:375-82.
Zhou XJ, Rakheja D, Yu X, Saxena R, Varizi ND, Silva FG. The aging kidney. Kidney Internat. 2008; (74): 710-20.
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985; 33: 278-85.
Stevens LA, Levey AS. Current status and future perspectives for CKD testing. Am J Kidney Dis. 2009; 53, Suppl 3: S17-S26.
Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005; 352(20):2049-60.
Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypert. 2006; 15: 610-16.
Doolan PD, Alpen EL, Theil GB. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med. 1962; 32:65-79.
Rose BD, Post TW. Circulación renal y tasa de filtración glomerular. En: Rose BD, Post TW, editores. Trastornos de los electrólitos y del equilibrio ácido-base. Madrid: Marbán; 2005. p. 21-70.
Douville P, Martel AR, Talbot J, Desmeules S, Langlois S, Agarrais M. Impact of age on glomerular filtration estimates. Nephrol Dial Transplant. 2009; 24: 97-103.
Roderick PJ, Atkins RJ, Smeeth L, Nitsch DM, Hubbard RB, Flectcher AE, et al. Detecting chronic kidney disease in older people; what are the implications? Age Aging. 2008; 37: 179-186.
Poggio ED, Rule AD. A critical evaluation of chronic kidney disease-should isolated reduced estimated glomerular filtration rate be considered a “disease”? Nephrol Dial Transplant. 2009; 24: 698-700.
Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis. 2008; 52(3):553-86.
Manjunath G, Tifhiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003; 63: 1121-9.
Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali, WA et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Internat. 2006; 69: 2155-2161.
Otero A, de Francisco A, Gayoso P, García F; EPIRCE Study Group. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrología. 2010; 30(1):78-86.
Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Trasplant. 2008; 23(4): 1117-21.
Nurko S. Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleve Clin J Med. 2006; 73(3): 289-97.
Agarwal AK. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc. 2006; 7(9 Suppl): S7-S12.
Wish JB, Coiné DW. Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of exiting therapies. Mayo Clin Proc. 2007; (8211): 1371-80.
Heras M, Guerrero MT, Fernández-Reyes MJ, Sánchez R, Muñoz A, Macías MC, et al. Las manifestaciones analíticas asociadas a la insuficiencia renal crónica: ¿a partir de qué grado de filtrado glomerular estimado las detectamos en ancianos? Rev Esp Geriatr Geront. 2009; 44:143-5.
Keith D, Nichols GA, Gullion C, Brown JB, Smith DH. Longitudinal follow-up and outcome among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164: 659-663.
Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, et al. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol. 2005; 16:201-209.
O´Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol. 2006; 17: 846-853.
Del Sol Otero-López M, Martínez Ocaña JC, Betancourt Castellanos L, Rodríguez Salazar E, García García M. Aplicabilidad clínica de dos índices pronósticos de mortalidad precoz en pacientes añosos incidentes en hemodiálisis. Nefrología. 2012; 32(2):213-220.
Keller F. Kidney function and age. Nephrol Dial Transplant. 1987; 2(5):382.
Álvarez Gregory JA. The value of a formula including haematocrit, blood and gender (HUGE) as a screening test for chronic renal insufficiency. J Nutr Health Aging. 2011; 15(6):480-4.
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
